Image Credit: STAT News
STAT+: Pharmalittle: We’re reading about Lilly strategy against compounders, Bristol’s antipsychotic, and more
Lilly is using a new line of attack against telehealth firms, accusing them in lawsuits of engaging in the corporate practice of medicine